AI Terminal
TREATT PLC
Director's Dealing • Mar 24, 2022
4700_dirs_2022-03-24_4c3e8532-00f6-46e2-ac08-843697129596.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9697F
Treatt PLC
24 March 2022
24 March 2022
TREATT PLC
("Treatt" or "the Company")
Notification of Transactions of a Person Closely Associated (PCA)
The Company was notified on 23 March 2022 that a PCA (Person Closely Associated with a PDMR) sold a total of 8,078 ordinary shares of the Company at a weighted average price of £10.80 per ordinary share, details of which are below.
The information contained in this notification is disclosed in accordance with the requirements of the EU Market Abuse Regulation.
| 1 | Details of the Person Closely Associated (PCA) | ||
| a) | Name | Tracey Smith | |
| 2 | Reason for the notification | ||
| a) | Position/status | PCA to Richard Hope, Chief Financial Officer | |
| b) | Initial notification/Amendment | Initial Notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Treatt Plc | |
| b) | LEI | 213800G40JM9F7G9LG39 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary share of 2 pence each GB00BKS7YK08 |
|
| b) | Nature of transaction | Sale of ordinary shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £10.816 £10.816 £10.773 |
1,946 1,142 4,990 |
||
| Aggregated information - Aggregated volume - Price |
8,078 £10.80 |
||
| e) | Date of the transaction | 23 March 2022 | |
| f) | Place of the transaction | London Stock Exchange, XLON |
Contact details
Anita Guernari
Company Secretary
++ 44 1284 770028
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGZGZFNDGGZZM